187 related articles for article (PubMed ID: 20929277)
41. Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions.
Valentini G; Mantelli A; Persico M; Tuccillo C; Del Vecchio Blanco G; Morisco F; Improta RD; Migliaresi S; Gualdieri L; Caporaso N
Clin Exp Rheumatol; 1999; 17(1):75-9. PubMed ID: 10084036
[TBL] [Abstract][Full Text] [Related]
42. Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-α polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients.
Tarragô AM; da Costa AG; Pimentel JP; Gomes ST; Freitas FB; Lalwani P; de Araújo AR; Victória Fda S; Victória MB; Vallinoto AC; Sadahiro A; Teixeira-Carvalho A; Martins-Filho OA; Malheiro A
Hum Immunol; 2014 Nov; 75(11):1075-83. PubMed ID: 25193024
[TBL] [Abstract][Full Text] [Related]
43. Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10.
Antonelli A; Ferrari SM; Frascerra S; Galetta F; Franzoni F; Corrado A; Miccoli M; Benvenga S; Paolicchi A; Ferrannini E; Fallahi P
Cytokine; 2011 Aug; 55(2):288-93. PubMed ID: 21601475
[TBL] [Abstract][Full Text] [Related]
44. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
[TBL] [Abstract][Full Text] [Related]
45. Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection.
Riva A; Laird M; Casrouge A; Ambrozaitis A; Williams R; Naoumov NV; Albert ML; Chokshi S
Hepatology; 2014 Aug; 60(2):487-96. PubMed ID: 24668726
[TBL] [Abstract][Full Text] [Related]
46. [Extrahepatic manifestations of chronic hepatitis C].
Ignatova TM; Aprosina ZG; Serov VV; Mukhin NA; Krel' PE; Semenkova EN; Popova IV; Tanashchuk EL
Ter Arkh; 1998; 70(11):9-16. PubMed ID: 9949448
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of HCV antibodies in autoimmune thyroid disease.
Testa A; Castaldi P; Fant V; Fiore GF; Grieco V; De Rosa A; Pazardjiklian MG; De Rosa G
Eur Rev Med Pharmacol Sci; 2006; 10(4):183-6. PubMed ID: 16910348
[TBL] [Abstract][Full Text] [Related]
49. [Role of hepatitis C virus in mixed cryoglobulinemia in patients with chronic hepatitis].
Adinolfi LE; Utili R; Attanasio V; Zampino R; Pizzella T; Nardiello S; Ruggiero G
Ann Ital Med Int; 1995; 10(2):85-8. PubMed ID: 7619656
[TBL] [Abstract][Full Text] [Related]
50. Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors.
Gragnani L; Piluso A; Giannini C; Caini P; Fognani E; Monti M; Petrarca A; Ranieri J; Razzolini G; Froio V; Laffi G; Zignego AL
Arthritis Rheum; 2011 May; 63(5):1446-51. PubMed ID: 21538321
[TBL] [Abstract][Full Text] [Related]
51. Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia.
Artoni E; Sighinolfi GL; Gatti AM; Sebastiani M; Colaci M; Giuggioli D; Ferri C
Occup Med (Lond); 2017 Jan; 67(1):64-67. PubMed ID: 27694373
[TBL] [Abstract][Full Text] [Related]
52. CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia.
Russi S; Vincenti A; Vinella A; Mariggiò MA; Pavone F; Dammacco F; Lauletta G
Eur J Intern Med; 2019 Aug; 66():48-56. PubMed ID: 31126779
[TBL] [Abstract][Full Text] [Related]
53. Abnormal CD4 + T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infection.
Kong F; Zhang W; Feng B; Zhang H; Rao H; Wang J; Cong X; Wei L
Virol J; 2015 Jul; 12():100. PubMed ID: 26129991
[TBL] [Abstract][Full Text] [Related]
54. Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis.
Rotondi M; Minelli R; Magri F; Leporati P; Romagnani P; Baroni MC; Delsignore R; Serio M; Chiovato L
Eur J Endocrinol; 2007 Apr; 156(4):409-14. PubMed ID: 17389454
[TBL] [Abstract][Full Text] [Related]
55. Mixed cryoglobulinemia in hepatitis C patients. GERMIVIC.
Cacoub P; Hausfater P; Musset L; Piette JC
Ann Med Interne (Paris); 2000 Feb; 151(1):20-9. PubMed ID: 10761559
[TBL] [Abstract][Full Text] [Related]
56. Increased T-cell sinusoidal lymphocytosis in liver biopsies in patients with chronic hepatitis C and mixed cryoglobulinemia.
Carmack S; Taddei T; Robert ME; Mistry P; Jain D
Am J Gastroenterol; 2008 Mar; 103(3):705-11. PubMed ID: 17970837
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).
Sène D; Limal N; Ghillani-Dalbin P; Saadoun D; Piette JC; Cacoub P
Rheumatology (Oxford); 2007 Jan; 46(1):65-9. PubMed ID: 16782735
[TBL] [Abstract][Full Text] [Related]
58. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study.
Ganne-Carrie N; Medini A; Coderc E; Seror O; Christidis C; Grimbert S; Trinchet JC; Beaugrand M
J Autoimmun; 2000 Mar; 14(2):189-93. PubMed ID: 10677250
[TBL] [Abstract][Full Text] [Related]
59. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
60. Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection.
Weng PJ; Fu YM; Ding SX; Xu DP; Lin A; Yan WH
Hum Immunol; 2011 May; 72(5):406-11. PubMed ID: 21377504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
